May 16, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
Walgreens Boots Alliance and Rite Aid last week said they’ve complied with the Federal Trade Commission’s second request for information on their merger deal. But it appears the FTC still wants to know more. The New York Post reported Tuesday that the FTC has issued civil investigative demands (CIDs) to Walgreens vendors and competitors to
May 4, 2017 by Chain Drug Review
Fred's, Fred's Pharmacy, Michael Bloom, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Pharmacy
MEMPHIS, Tenn. — Fred’s Pharmacy reported declined sales for April and its fiscal 2017 first quarter, though seasonal business lifted same-store sales for the month. Fred’s said Thursday that sales for the four weeks ended April 29 totaled $159.1 million, down 3% from $163.9 million a year earlier. April same-store sales edged up 1.2% year
April 24, 2017 by Chain Drug Review
Alden Global Capital, Fred's, Fred's board of directors, Fred's Pharmacy, Heath Freeman, Michael Bloom, Steven Rossi, Thomas Tashjian, Timothy Barton, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has appointed two new board members as part of an agreement with hedge fund Alden Global Capital LLC, the discount and pharmacy chain’s largest shareholder. Fred’s said Monday that Steven Rossi, chief executive officer of Digital First Media, and Timothy Barton, founder and former CEO of Freightquote.com, have been named
April 24, 2017 by Chain Drug Review
Adam Fein, Affordable Care Act, American Health Care Act, Bob Kirby, CFRA, chain drug industry, chain drug stores, David Silverman, Drug Channels Institute, Fitch Ratings, Fred's, health insurance coverage, Joseph Agnese, Pembroke Consulting, Walgreens-Rite Aid merger
2017, Business, Featured Articles, Issue 04-24-2017, Issues, Leading Headlines, News, Retail News
NEW YORK — Entering the second quarter of 2017, the chain drug industry was awaiting answers to a couple of big, lingering questions. First, what will the chain drug landscape look like? A significant change in the field of players is likely in store pending antitrust clearance of Walgreens Boots Alliance Inc.’s (WBA’s) deal to
April 22, 2017 by Scot Meyer and Chain Drug Review
Fred's, Mike Bloom, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) executive vice chairman and chief executive officer Stefano Pessina has expressed confidence that the company’s planned merger with Rite Aid Corp. will be approved by the end of July. “I am still optimistic that we will bring this deal to a successful conclusion, but there is no
April 6, 2017 by Chain Drug Review
Fred's, Fred's Pharmacy, Linda Longo-Kazanova, Michael Bloom, Steven Fitzpatrick, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. reported declined sales and net losses for its 2016 fourth quarter and fiscal year as it awaits regulatory approval to buy up to 1,200 drug stores in connection with the Walgreens-Rite Aid merger. Fred’s said Thursday that sales for the fourth quarter ended Jan. 28, 2017, fell 4.5% to $529.7
April 4, 2017 by Chain Drug Review
Fred's, Jim Cramer, Scott Mushkin, video, Walgreens Boots Alliance, Walgreens-Rite Aid, Walgreens-Rite Aid merger, Wolfe Research
Videos
Like everyone else waiting for the wrap-up of the Walgreens-Rite Aid merger, investment pundit Jim Cramer of TheStreet.com and CNBC’s “Mad Money” is getting impatient over the plodding antitrust review negotiations. Now approaching its 18th month, Walgreens Boots Alliance’s planned acquisition of Rite Aid has a deal end date of July 31, as per an
April 3, 2017 by Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, WBA-Rite Aid deal
2017, Issue 04-03-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is reportedly prepared to sell additional stores and other assets to Fred’s Inc. in an effort to win Federal Trade Commission approval for its merger with Rite Aid Corp. WBA, which had initially agreed to sell 865 Rite Aid stores to Fred’s, is planning to raise that
April 3, 2017 by Brian Bossetta
Christopher Bodine, CVS Caremark, Fred's, Mike Bloom, Peter Bocian, Safeway, Thomas Tashjian
2017, Issue 04-03-2017, Issues, News
MEMPHIS — Fred’s Inc. recently announced three new members — industry veterans Christopher Bodine, Peter Bocian and Mike Bloom — to its board of directors. At the same time, the company announced the retirement of Michael Hayes, John Eisenman and Jerry Shore from the board. During his 24-year tenure at CVS Caremark Corp., Bodine held
March 31, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Sean Reyes, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Walgreens Boots Alliance has gone ahead and set a deadline for the Federal Trade Commission to approve its deal to acquire Rite Aid Corp. According to the New York Post, WBA has “certified compliance” in its application, meaning that it has provided the FTC with the information needed to determine if the Walgreens-Rite Aid merger
March 15, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
The latest scuttlebutt on the Walgreens-Rite Aid merger: Walgreens Boots Alliance looks to be divesting even more stores and other assets to Fred’s. Citing anonymous sources, Bloomberg reported Tuesday that WBA is “nearing an agreement” to raise the number of stores to sell to Fred’s as well as include distribution centers, software and staff. No
March 8, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
It has been over 14 months and two deal date extensions since the announcement of Walgreens Boots Alliance’s agreement to acquire Rite Aid Corp. Now WBA may act to push the Federal Trade Commission to come to a decision. The New York Post reported that WBA may claim that it has “certified compliance” in its
March 7, 2017 by Chain Drug Review
Christopher Bodine, Fred's, Fred's board, Fred's Pharmacy, Fred’s Pharmacy board of directors, Jerry Shore, John Eisenman, Michael Bloom, Michael Hayes, Peter Bocian, Rite Aid, Thomas Tashjian, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has overhauled its board of directors, including the appointment of chief executive officer Michael Bloom and retail industry veterans Christopher Bodine and Peter Bocian as members. Fred’s said Tuesday that Bloom, Bodine and Bocian join the board effective immediately. Former Fred’s CEOs Jerry Shore and Michael Hayes and longtime director
March 2, 2017 by Chain Drug Review
Fred's, Michael Bloom
Business, Leading Headlines, Retail News
MEMPHIS, Tenn. — Despite a lift from its pharmacy business, Fred’s Inc. posted decreased revenue and same-store sales for February. The discount and pharmacy chain said Thursday that for the four weeks ended Feb. 25, sales totaled $165.4 million, down 3.5% from $171.4 million a year earlier. Comparable-store sales for February fell 4%, compared with